Infertility in female. Female infertility associated with anovulation
Conditions
Interventions
Intervention 1: Intervention group: prescription two tablets of Medroxyprogesterone containing 5 mg
manufactured by Abouryan company
from the first day of the visit until receiving HCG. Intervention 2: Control group: Receive routine treatment.
Sponsors
Research vice-chancellorship, Guilan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 50 Years
Inclusion criteria
Inclusion criteria: All infertile patients with oocyte donation undergoing ICSI
Exclusion criteria
Exclusion criteria: In the oocyte donor:Age over 35 years, irregular menstruation, antral follicle count less than 5 and more than 12, FSH more than 10 on the third day of menstruation, cystic ovaries and endometriosis, BMI greater than 25, not having at least one child and the presence of any disease affecting ovulation (such as thyroid disease and high prolactin levels) In the oocyte receptor: Age over 50 years , any systemic disease including hypertension, diabetes, chronic diseases, liver and kidney, problem in the uterus and tubes (including: leiomyoma, polyp, adenomyosis, ashren and hydrosalpinx and etc.) and there is male factor
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fertility success. Timepoint: Two weeks after fetal transfer. Method of measurement: Pregnancy test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Seeing fetal heart rate. Timepoint: 6 weeks after fetal transfer. Method of measurement: Vaginal ultrasound. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZiba Zahiri
Rasht University of Medical Sciences
Outcome results
None listed